InvioCare ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  4.8% 7.0% 2.9% 10.4% 26.9%  
Credit score (0-100)  46 34 57 23 1  
Credit rating  BBB BBB BBB BB B  
Credit limit (kDKK)  -0.0 0.0 0.0 0.0 -0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  1,259 7,066 2,703 2,368 1,531  
EBITDA  402 4,774 599 -94.3 -644  
EBIT  160 4,289 338 -233 -781  
Pre-tax profit (PTP)  103.5 4,261.9 307.5 -265.5 -805.2  
Net earnings  103.5 4,261.2 307.5 -265.5 -805.2  
Pre-tax profit without non-rec. items  104 4,262 308 -265 -805  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  1,239 754 494 688 608  
Shareholders equity total  -4,402 -141 166 -99.2 -904  
Interest-bearing liabilities  5,430 1,002 1,017 1,019 1,011  
Balance sheet total (assets)  1,958 1,988 2,295 1,921 1,281  

Net Debt  5,162 143 139 464 797  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  1,259 7,066 2,703 2,368 1,531  
Gross profit growth  -52.9% 461.1% -61.7% -12.4% -35.4%  
Employees  4 5 5 6 5  
Employee growth %  0.0% 25.0% 0.0% 20.0% -16.7%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,958 1,988 2,295 1,921 1,281  
Balance sheet change%  -39.9% 1.5% 15.5% -16.3% -33.3%  
Added value  402.3 4,773.9 598.8 27.9 -644.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -485 -970 -521 55 -216  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 2.0 3.0 -1.0 -2.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  12.7% 60.7% 12.5% -9.8% -51.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  2.3% 101.0% 15.3% -10.8% -37.1%  
ROI %  2.9% 130.5% 29.5% -21.1% -76.8%  
ROE %  4.0% 216.0% 28.6% -25.4% -50.3%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  -69.2% -6.6% 7.2% -4.9% -41.4%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  1,283.2% 3.0% 23.3% -492.1% -123.7%  
Gearing %  -123.4% -709.1% 611.4% -1,027.0% -111.8%  
Net interest  0 0 0 0 0  
Financing costs %  1.0% 0.8% 3.0% 3.2% 2.6%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.1 1.0 1.1 0.8 0.2  
Current Ratio  0.1 1.1 1.5 1.1 0.5  
Cash and cash equivalent  268.4 858.4 877.2 555.2 214.3  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -5,698.0 125.0 584.9 120.3 -615.0  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  101 955 120 5 -129  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  101 955 120 -16 -129  
EBIT / employee  40 858 68 -39 -156  
Net earnings / employee  26 852 62 -44 -161